Communicable Disease Control Branch, Health Regulation and Protection, Department of Health and Wellbeing, Government of South Australia, February 2021 The South Australian HIV PEP Hotline (1800 022 226) provides advice, triage and information to members of the community who may have been exposed to HIV, and if assessed as eligible, directs them to their nearest PEP access point. Most HIV PEP...
AFAO, December 1st, 2020 Each year, AFAO develops the ‘HIV in Australia’ summary of the latest key HIV data and stats. The latest summary has just been released. Key points: Rapid uptake of PrEP, in combination with treatment as prevention, has led to declines in HIV notifications among Australian-born gay and bisexual men. Across the last six years, there has been a 44% decrease in HIV...
Khaw, C., Zablotska-Manos, I. & Boyd, M.A. Sex Res Soc Policy (2020). Abstract: Background Chemsex, the intentional combining of sex with the use of particular psychoactive substances typically crystal methamphetamine, gamma-hydroxybutyrate(GHB)/gamma butyrolactone(GBL), mephedrone, and ketamine has been reported among men who have sex with men (MSM). Chemsex is more common among MSM than in...
ACON, October 28, 2020 The latest 2020 SWASH report was released on 28th October 2020 as part of a series of Mental Health month events. The SWASH survey is a comprehensive survey of important health issues relevant to lesbian, bisexual, queer and other non-heterosexual identifying women engaged with Sydney’s lesbian, gay, bisexual, transgender, intersex and queer (LGBTIQ) communities. SWASH has...
Okoli C, Van de Velde N, Richman B, et al Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries Sexually Transmitted Infections Published Online First: 30 July 2020. doi: 10.1136/sextrans-2020-054551 Abstract: Objectives ‘Undetectable equals Untransmittable’ (U=U) is an empowering message that may enable people...
nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...